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Abstract
Introduction: HIV-related stigma impacts the quality of life and care management of HIV-infected and HIV-affected individuals,
but how we measure stigma and its impact on children and adolescents has less often been described.
Methods: We conducted a systematic review of studies that measured HIV-related stigma with a quantitative tool in paediatric
HIV-infected and HIV-affected populations.
Results and discussion: Varying measures have been used to assess stigma in paediatric populations, with most studies utilizing
the full or variant form of the HIV Stigma Scale that has been validated in adult populations and utilized with paediatric
populations in Africa, Asia and the United States. Other common measures included the Perceived Public Stigma Against
Children Affected by HIV, primarily utilized and validated in China. Few studies implored item validation techniques with the
population of interest, although scales were used in a different cultural context from the origin of the scale.
Conclusions: Many stigma measures have been used to assess HIV stigma in paediatric populations, globally, but few have
implored methods for cultural adaptation and content validity.
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Introduction
In 2013, there were an estimated 3.2 million children under
the age of 15 years living with HIV, with over 90% living
in sub-Saharan Africa [1]. Families describe HIV stigma as
a major barrier to access and adherence to HIV care for
children, but relatively little is known about the experiences
of HIV stigma among families with HIV-infected children and
adolescents or how stigma is related to their physical, psycho-
logical and social outcomes [26]. For example, stunted
growth and delayed bodily development with perinatal HIV
infection may be sources of stress and anxiety for adoles-
cents and lead to social isolation [7]. Families also report that
the fear of stigma prevents them from taking important
transitional steps such as disclosing a child’s HIV status to the
child, as they worry about subsequent stigma [8]. The impact
of HIV stigma likely varies over a child’s development from
childhood into adolescence and may impact family members
in the same household in different ways. HIV stigma may also
impact HIV-affected individuals [9]. For example, children
orphaned by parental HIV infection may be affected by HIV
stigma and discrimination [10].
The objective of this review is to examine the construc-
tion and utilization of HIV stigma measures in paediatric
HIV-infected and HIV-affected populations, globally. Reliable
and valid measures of HIV-related stigma and its closely
related constructs are needed to track the impact of in-
terventions targeting stigma reduction. To date, there are
relatively few data on how to measure HIV stigma among
paediatric populations and in resource-limited settings. To
address this gap, we sought to identify and describe quan-
titative HIV stigma measures used in paediatric populations
that are HIV-infected or HIV-affected, with critical examina-
tion of the creation of scales or measurement tools for use
within paediatric populations.
Methods
To conduct this systematic review, we searched online data-
bases including MEDLINE, EMBASE, PsycINFO, Academic Search,
ERIC, CINAHL, Social Work Abstracts, Scopus and Web of
Science as of 15 January 2015.The search strategy was (‘‘social
stigma,’’ ‘‘stereotyping,’’ ‘‘prejudice,’’ ‘‘discrimination,’’ ‘‘social
perception,’’ ‘‘shame,’’ ‘‘social marginalization,’’ ‘‘social isola-
tion,’’ ‘‘social distance,’’ ‘‘social exclusion,’’ ‘‘fear,’’ ‘‘self
concept’’ OR ‘‘self perception’’) AND (‘‘human immunodefi-
ciency virus,’’ ‘‘Acquired Immunodeficiency Virus,’’ ‘‘Acquired
Immunodeficiency Syndrome’’ OR ‘‘HIV Infections’’) AND
(‘‘paediatrics,’’ ‘‘child’’ OR ‘‘adolescent’’). The search was sup-
plemented by truncated keywords (e.g. stereotyp*) and
bibliography review.
Because the systematic review aimed to explore stigma
measures previously utilized for children, in addition to mea-
sure development, we did not include specific search terms
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for measurement tools (e.g. ‘‘measure’’ and ‘‘questionnaire’’).
Inclusion criteria were the following: (1) administering a
quantitative HIV/AIDS-related stigma measurement tool,
(2) study population including HIV-infected or HIV-affected
children or adolescents 18 years of age, (3) peer-reviewed
publication and (4) published in English language. Since many
studies explored stigma with paediatric populations and their
caregivers, we only included studies that utilized a stigma
tool with the paediatric sub-population. As this was a youth-
focused review, we excluded studies that technically fit
inclusion criteria by including individuals B18 years of age,
but which had fewer than five participants under age 18
because their target participants were not children, adoles-
cents or young adults. We included studies from all geo-
graphic locations. Articles that reported findings from the
same study population, using the same measurement tools
over the same period of time were counted as a single study,
for which we combined the results of their multiple pub-
lications into a single report.
Two authors (NTT and CIM) independently reviewed
all articles and determined whether the studies met the
inclusion criteria. Disagreements were discussed with a third
reviewer (RCV) to reach consensus. Data regarding study
location, target population, stigma measures used and any
correlates of stigma measured were extracted from the
included studies.
To assess the quality of the HIV/AIDS stigma measures,
a quality criteria tool by Terwee [11] was utilized. Content
validity was assessed based on the extent to which the
domain of interest was comprehensively sampled by the
questionnaire items. Internal consistency assessed the extent
to which items on a scale were inter-correlated. Construct
validity was scored as the extent to which scores on a
questionnaire relate to measures in a manner consistent with
a derived hypothesis. Each criterion was scored by two
authors (NTT and CIM) with a () for meeting the criterion,
(?) for doubtful design, () for studies that reported the
criterion but did not meet the appropriate threshold and
(0) was scored for no information provided. From studies
meeting inclusion criteria, the revised quality criteria tool was
applied to 22 of the studies.
Results and discussion
The search terms identified 7004 titles, which were reviewed
to determine whether they met the inclusion criteria.
Following the title review, 1110 abstracts were reviewed,
and then 348 full articles were reviewed. Twenty-seven
articles met the inclusion criteria (Figure 1).
Of these 27 articles, the compilation of the multiple
publications describing the same study populations resulted
in 22 unique studies to include in the final analysis [10,1318].
Some studies with the same population used different stigma
measures and were therefore considered separate studies in
this review (see Table 1).
Populations
Of the 22 final articles, eight studies were conducted in the
United States [9,16,1924], five in Africa [10,15,2527], eight
in Asia [2835] and one in Sweden [36]. Seven unique studies
had large sample sizes (N900): four studies with the same
orphaned, vulnerable children and comparison children were
conducted in China [3134], and three were conducted in
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Figure 1. PRISMA database search results [12].
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Africa [10,15,25]. Five of the studies focused on HIV-affected
children [10,25,27,31,37], nine focused on HIV-infected
children [16,19,21,23,24,26,28,29,36] and eight focused on
comparing groups of HIV/AIDS orphans, orphans from other
illnesses and vulnerable children [9,20,22,30,3235].
HIV-infected population and stigma scales
Nine of the studies focused on implementing or validating
a stigma scale with HIV-infected paediatric or young adult
participants [16,19,21,23,24,26,28,29,36]. Four of these stu-
dies focused on special populations: two recruited only
participants who were young men who have sex with men
(MSM) [19,24], one recruited only behaviourally infected
female participants [26] and one recruited only substance-
using young people [23]. The five remaining studies, all of
which were smaller studies (NB900), included general
populations of HIV-infected youth [16,21,28,29,36].
HIV-affected population and stigma scales
Seven unique studies administered stigma measures to
HIV-affected children [9,15,20,22,27,30,35]. Two studies, Fair
et al. [22] and Murphy et al. [20], measured HIV stigma in
children of HIV-infected mothers.
The remaining studies assessed between-group differences
among HIV-affected children (HIV/AIDS-orphaned children
and vulnerable children) and children not affected by HIV
(children orphaned by other causes) [14,15,27,33,34]. Boyes
and Cluver [15] and Cluver et al. [10,25] found that HIV-
affected youth in South Africa had higher stigma scores than
non-affected youth with the Brief Stigma by Association
Scale. Onuoha and Munakata [27] used the modified Detroit
Area Study Measure of Discrimination as a measurement of
HIV stigma to assess social discrimination of children orphaned
by AIDS in South Africa and Uganda and found that HIV/AIDS-
orphaned children reported higher levels of discrimination
and higher levels of psychological distress than the comp-
arison groups. Zhao et al. [35] explored HIV/AIDS-related
knowledge and HIV stigma in comparison groups of children
orphaned by HIV/AIDS, children living with HIV-infected
parents and comparison children that were non-HIV affected
and found that within the children in the HIV-affected groups,
those children with higher HIV/AIDS knowledge had lower
stigma scores. In China, Zhao et al. [34] found that, in a
comparison study with HIV/AIDS orphans and vulnerable
children, the Stigma Against Children Affected by HIV (SACAA)
Table 1. Study locations and populations and stigma measures used
Author and year Location Population Stigma measure Correlates explored
Boyes et al. (2013) South Africa HIV affected (N723) Brief HIV Stigma by Association Scale
(a0.780.87)
Stigma by groups
Chi et al. (2014) China aHIV affected (N1625) SACAA (a0.840.88) Depression
Clum et al. (2009) United States HIV infected (N147) HIV Stigma Scale Subscales (a0.90) Depression
Cluver et al. (2008) South Africa aHIV affected (N1025) Modified HIV Stigma Scale (a0.88) Stigma by groups
Cluver. et al. (2013) South Africa HIV affected (N6002) Brief HIV Stigma by Association Scale (a0.87) Stigma by groups
Dowshen (2009) United States HIV infected (N42) HIV Stigma Scale (a0.790.94) Depression
Fair (2008) United States HIV affected (N10) Modified HIV Stigma Scale Stigma
Fongkaew (2014) Thailand HIV infected (N30) HIV Stigma Scale (a0.95) Adherence
Lin X et al. (2010) China aHIV affected (N1625) Perceived Stigma Scales (a0.86, 0.87) Stigma by group
Mason et al. (2010) United States HIV affected (N27) Brief Stigma by Association Scale (a0.86) Stigma
Mavhu et al. (2013) Zimbabwe HIV infected (N10) New questions
Murphy et al. (2006) United States HIV affected (N118) Modified HIV Stigma Scale (a0.80 and 0.68) Delinquency
Onuoha & Munakata
(2010)
South Africa
and Uganda
HIV affected (N952) Detroit Measure of Discrimination (a0.78) Social discrimination
Radcliffe et al. (2010) United States HIV infected (N40) Swendeman’s Scale Sexual risk
behaviours
Rongkavilit et al. (2010) Thailand HIV infected (N70) Thai Youth HIV Stigma Scale (a0.96) Mental health,
HrQoL
Swendeman et al. (2006) United States HIV infected (N147) Modified Enacted and Perceived Scales
(a0.530.83)
Social rejection
Wang (2012) China aHIV affected (N1221) SACAA, Perceived and Enacted Stigma Scales
(a0.88, 0.88)
Trauma, depression
Wright et al. (2007) United States HIV infected (N48) Brief Measure of HIV Stigma (a0.720.88) Stigma
Wiklander et al. (2013) Sweden HIV infected (N58) HIV Stigma Scale for children-8 (a0.780.81) HrQoL
Zhao et al. (2012) China aHIV affected (N1625) SACAA, Enacted and Perceived Scales (a0.88) Mental health
Zhao et al. (2010) China aHIV affected (N1625) SACAA, Perceived Stigma Scale (a0.86) Mental health
Zhao et al. (2011) China HIV affected (N1625) New questions (a0.87) AIDS knowledge
aRepresents studies with the same population studied, but with different stigma scales or subscales used.
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measure had good construct validity and was positively
associated with psychopathological symptoms and negatively
associated with well-being in both HIV-affected children and
comparison children.
Stigma scales
Many different HIV stigma scales were used in paediatric
populations. Some studies utilized existing measures, but
with modifications (see Table 2) and others developed their
own questions to measure stigma.
The HIV Stigma Scale
The HIV Stigma Scale (HSS-B) developed by Berger et al. [38]
was the most frequently utilized and modified assessment
tool. Developed from two rounds of content review and vali-
dated in a large, diverse sample of HIV adults in the United
States, the scale consists of 40 items divided into four
subscales: personalized stigma, disclosure concerns, negative
self-image and concern with public attitudes toward people
with HIV. Each item is measured on a 4-point scale. Dowshen
et al. [19] utilized the full HSS-B for their study involving
HIV MSM young adults in United States. Confirmatory
factor analysis was bypassed, but Cronbach’s alphas were pro-
vided for total scale score (0.94) as well as disclosure concerns
(0.79), personalized stigma (0.93), negative self-image (0.84)
and public attitudes (0.91) subscales. To assess HIV stigma in
HIV-infected adolescent females in the United States, Clum
et al. [16] used the HSS with the negative self-image and
disclosure subscales with a Cronbach’s alpha of 0.90.
In Sweden, Wiklander et al. [36] shortened and modified
the HSS for HIV Swedish youth. The authors utilized a
‘‘think-aloud’’ methodology with the target population, factor
analysis of items from the HSS and qualitative review by an
expert panel. The subsequent 8-item scale, entitled HIV Sigma
Scale for Children, HSSC-8, included only two items for the
disclosure subscale, and the personalized stigma subscale was
removed entirely [36]. Murphy et al. [20] utilized 19 items
from the HSS after conducting confirmatory factor analysis on
the original HSS subscale items. Fair et al. [22] andMurphy et al.
[20] modified the questions to ask if the children perceived
stigma because their mothers had HIV, but were not otherwise
altered for the young, sero-negative target population [39].
Mason et al. [9] created a 23-item HIV Stigma by Associa-
tion Scale for Adolescents from content analysis with the
target population, cognitive interviews and assessments of
content validity of the full HSS items to reflect stigma for
children of HIV-infected mothers. Boyes et al. [15] further
modified Mason et al.’s [9] scale for South African HIV-affected
youth through qualitative interviews and item selection,
resulting in a validated 10-item Brief Stigma by Association
Scale, which was further examined in South African HIV-
affected populations with Cluver et al. [25].
Wright et al. [21] administered the full HSS to 48 HIV-
infected participants and modified the measure to create a
Brief Measure of Stigma for HIV-positive youth, a 10-item
scale called the Brief Stigma Scale. Overall, the Brief Stigma
Scale showed good internal consistency and validity. In South
Africa, Cluver et al. [10] created a 4-item stigma scale based
on Wright et al.’s [21] Brief HSS and adapted the scale for
non-infected orphans using qualitative interviews with the
target population, literature review and expert input.
In Thailand, Rongkavilit et al. [29] and Fongkaew et al. [28]
used translated versions of the full HSS to assess stigma in Thai
youth living with HIV. Rongkavilit et al. [29] utilized the full HSS
on Thai youth living with HIV/AIDS and created an abbreviated
12-item scale through factor analysis and found no overall dif-
ferences between the new scale and the HSS for the popula-
tion studied. Fongkaew et al. [28] utilized a mixed methods
approach for assessing HIV stigma in the Thai youth population
and found that qualitative findings corroborated the stigma
scores, particularly in the personalized stigma subscale.
The Perceived Public Stigma Against Children Affected by
HIV Scale
One stigma scale was used in China with additional stigma
subscales by five studies in HIV-affected populations [3034].
Zhao et al. [34] created the Perceived Public Stigma Against
Children Affected by HIV/AIDS (SACAA), which measures
children’s perceptions of public stigma against affected
children. The SACAA was developed based on a literature
review of stigma measures, qualitative fieldwork with HIV-
affected participants in China and investigator input. The
SACAA consists of 10 items, measured on a 4-point scale,
with subscales on social exclusion, purposive avoidance and
Table 2. Development of new stigma scales
Author and year Original scale used New scale items
Boyes (2013) HIV Stigma by Association Scale for Adolescents Brief Stigma by Association Scale
Chi (2014) New Enacted Stigma Scale
Cluver (2008) HIV Stigma Scale 4-item Modified HIV Stigma Scale
Mason (2010) HIV Stigma Scale HIV Stigma by Association Scale for Adolescents
Mavhu (2013) New Questionnaire with Stigma Domains
Rongklavilit (2010) HIV Stigma Scale Thai Youth HIV Stigma Scale
Swendeman (2006) Perceived Stigma and Enacted Stigma (Sowell 1997) Shortened Perceived Stigma and Enacted Stigma
Wikilander (2013) HIV Stigma Scale HSSC-8
Wright (2007) HIV Stigma Scale Brief Measure of Stigma (HSS-B)
Zhao (2010) New SACAA
Zhao (2011) New Personal Stigma Toward People Living with HIV/AIDS
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perception of being inferior. Chi et al. [30] administered the
SACAA to HIV-affected children in China along with a 12-item
Enacted Stigma Scale; Wang et al. [32] utilized the SACAA in
addition to a 14-item Enacted Stigma Scale; and Lin et al. [31]
utilized the SACAA and a 10-item Personal Stigma Scale
with positive ratings for content validity and internal
consistency. Zhao et al. [33] compared the SACAA with three
other stigma scales: Perceived Public Stigma Against People
Living with HIV/AIDS (PLWHA) (Cronbach’s alpha0.86),
Personal Stigmatizing Attitudes Against PLWHA (Cronbach’s
alpha0.87) and Enacted Stigma scales (Cronbach’s
alpha0.88). Zhao et al. [33] found that the different stigma
measures captured different psychosocial outcomes of inter-
est, and thus, each scale was slightly different in the type of
stigma being measured.
Other stigma scales
In the United States, Swendeman et al. [23] modified a
pre-existing scale for use with substance-using HIV-infected
young women. Based on literature review and focus groups
with HIV women, Sowell et al. [40] developed the HSS-S.
The HSS-S was modified by Swendeman et al. [23] and
resulted in 11 enacted stigma item and 7 perceived stigma
items. Although no mention of target population involvement
was made, factor analyses were performed and Cronbach’s
alphas provided. Two enacted stigma questions were ex-
cluded due to low analysis values, and the remaining divided
into avoidance, abuse and social rejection subscales (alphas
0.71, 0.59 and 0.53), while the perceived stigma items were
divided into avoidance, social rejection and shame subscales
(alphas0.83, 0.67 and 0.69). The seven perceived items were
utilized by Radcliffe et al. [24] to assess stigma among young
HIV MSM in the United States. The response format was
altered to yes/no, but items were not otherwise altered, and no
factor analyses or Cronbach’s alphas were reported.
In Africa, Mavhu et al. [26] used a mixed methods
approach to assess stigma of HIV Africaid support group
attendees. The quantitative measure was developed from
questionnaires previously validated in Zimbabwe as well as
newly developed and pretested questions. Factor analysis
and Cronbach’s alpha were not mentioned for this measure
of stigma. Onuoha and Munakata [27] used the modified
Detroit Area Study Measure of Discrimination to assess social
discrimination of children orphaned by AIDS in South Africa
and Uganda. Although the target population was not in-
volved in item selection, the measure was administered to a
focus group of adolescent children in both countries to assess
cultural validity in young children, and the Cronbach’s alpha
for the scale was 0.78.
In China, Zhao et al. [35] developed new questions to
assess children’s attitudes toward PLWHA. The 10 questions
were developed from a literature review on HIV stigma with
children affected by HIV/AIDS and had a Cronbach’s alpha
of 0.87.
Cultural adaptations of stigma scales
For quantitative tools that measure psychosocial constructs
such as HIV stigma, common research procedures suggest
that researchers assess the cultural relevance and validity
of the tool if it is being used in a cultural context different
from where the tool originated. Many studies in this review
adapted pre-existing HIV stigma measures to refine items for
use with paediatric populations or target populations [9,2022];
however, only three studies revised HIV stigma tools within
the cultural context of interest, using the target popu-
lation as panel experts or in qualitative inquiry to address
cultural relevance of stigma items [15,34,36] Fongkaew et al.
[28] used a pre-existing Thai translation of the HSS that
had previously been used with a Thai adult population and
Rongkavilit et al. [29] conducted a factor analysis of the Thai
translated scale, which eventually resulted in the Thai Youth
HSS. Mavhu et al. [26] utilized qualitative inquiry to help
guide question construction for the stigma items asked of
HIV-infected children in Zimbabwe. The study does not
discuss any further factor analysis conducted for the items
constructed with the target population.
Quality assessment
Assessed quality varied greatly across the studies (see Table 3).
The studies designed to create and validate measures of
stigma varied significantly in their quality, which may carry
implications for the validity of the scales they created. On
the quality criteria rating scale, only the scales developed by
Boyes et al. [15] and Zhao et al. [34] received positive ratings
for both content validity and internal consistency. Although
Mason et al. [9] and Wiklander et al. [36] received positive
ratings for content validity, they received indeterminate ratings
for internal consistency due to their small sample sizes.
Rongkavilit et al. [29] and Wright et al. [21] similarly received
indeterminate internal consistency ratings due to small
sample sizes and also received negative ratings for content
validity, as they did not adapt items for age or culture.
Discussion
This systematic review sought to explore HIV stigma in
paediatric HIV-infected and HIV-affected populations and
how it can best be measured. Many studies utilized existing
stigma measures and modified the measures to better assess
the construct of stigma within their population of interest
(e.g. HIV-infected children, HIV-affected children and children
orphaned by HIV/AIDS). Based on the results of the sys-
tematic review, we found that, among the relatively small
group of measures developed for measuring HIV stigma, very
few have been validated for children or used in resource-
limited settings. Those that have been developed and vali-
dated with children were primarily used with HIV-affected,
rather than HIV-infected, children.
The HSS by Berger et al. [38], which has been extensively
tested and validated in adult populations, was the most
frequently utilized measure in the paediatric populations
reviewed. Using measures previously validated among adults
may not directly relate to HIV-infected or HIV-affected children.
Children may be exposed to different social environments
or different forms of stigma than HIV-infected adults and
therefore may not experience or report discrimination in the
same manner as adults. In addition, it is difficult to know how
well the item construction or vocabulary is understood by
children as this has seldom been examined. Therefore, future
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studies with paediatric HIV-exposed or HIV-infected popula-
tions should aim to formulate developmentally appropriate
HIV stigma questions to best measure the impact of HIV
stigma on the paediatric population. Qualitative investiga-
tion, including cognitive interviewing to assess the under-
standing, comprehension, and recall of children related to
these questionnaire items would be useful.
Across the literature on HIV stigma, the number of studies
that utilized a quantitative measure of paediatric HIV stigma
was extremely limited. Of those studies, the majority in-
cluded only small participant sample sizes of less than 200.
There were no large-scale studies (with N200) done in the
United States, Europe or South America, nor were there any
large studies focusing on children living with, rather than
affected by, HIV/AIDS. The difference in experiences and
effects of HIV stigma among paediatric HIV-affected and HIV-
infected children remains unknown. It is plausible that the
effects of experiencing HIV stigma are more harmful to the
psychosocial development and well-being of HIV-infected
children than for HIV-affected children.
Moreover, the long-term impact of stigma on HIV-infected
children as they become adolescents and adults has not been
studied among the large populations of children currently
growing up with HIV in resource-limited settings. As HIV-
infected adolescents are the only group of PLWHA among
whom the death rate continues to increase, it is critical that
we evaluate factors shaping the lives of these youth [41].
Adolescence is a developmental stage in which the opinions
and perceived judgments of peers hold particularly strong
weight. Future research should also explore the impact of
stigma at the various developmental stages of children,
adolescents and adults. The relationship of HIV stigma and
medication adherence also yielded mixed results, and the
measures themselves also varied [26,28]. With the subjectivity
of qualitative inquiry, the qualitative measures of addressing
adherence may not have accurately captured the association
of stigma and adherence. The clinical impact of stigma on
children and adolescents remains to be explored.
The majority of the studies in this review were conducted
in the United States, Asia and Africa. In a review of HIV/
AIDS Stigma by Mahajan et al. [42], the authors called for
validation of stigma measures in diverse settings. We found
that tools that were modified from pre-existing tools and
conducted in a similar cultural context had consistent results
Table 3. Quality criteria checklist scoring
Quality criteria
() Meeting
criteria
() No information
provided
(?) Doubtful
design
(0) Reported criteria but
did not meet threshold
Content validity Cluver (2008) Dowshen (2009) Mavhu (2013)
Wiklander (2013) Fongkaew (2014) Lin (2010)
Mason (2010) Fair (2008) Zhao (2012)
Boyes (2013) Murphy (2006) Zhao (2011)
Zhao (2010) Rongkalivit (2010) Chi (2014)
Onuoha (2010) Wright (2007) Clum (2009)
Radcliffe (2010)
Swendenman (2006)
Cluver (2013)
Internal consistency Dowshen (2009) Mavhu (2013) Fongkaew (2014)
Murphy (2006) Fair (2008)
Cluver (2008) Rongkalivit (2010)
Boyes (2013) Wright (2007)
Cluver (2013) Wiklander (2013)
Swendenman (2006) Mason (2010)
Lin (2010) Onuoha (2010)
Zhao (2012) Radcliffe (2010)
Zhao (2010) Zhao (2011)
Chi (2014) Clum (2009)
Construct validity Wright (2007) Mason (2010) Fongkaew (2014) Dowshen (2009)
Wiklander (2013) Fair (2008) Murphy (2006)
Boyes (2013) Rongkavilit (2010)
Radcliffe (2010) Cluver (2008)
Swendeman (2006) Cluver (2013)
Lin (2010) Onuoha (2010)
Zhao (2012) Mavhu (2013)
Zhao (2010) Zhao (2011)
Chi (2014) Clum (2009)
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with psychosocial constructs [10,15,25]. This suggests that,
even with the modifications made, the overall tool had
consistency in measuring the same construct of stigma. Some
of the studies that utilized similar stigma tools but had
varying psychosocial results used different psychosocial con-
struct tools and populations, thus producing contradictory
results. Without more rigorous evaluation of these con-
structs, the cause and effect are not clear.
This review also reveals the need to create or adapt HIV
stigma scales for cultural relevance and significance. In
the systematic evaluation of the quality of the studies, the
biggest challenge for content validity was how few studies
included any modification for age or culture. Using consistent
measures is an important goal for comparisons across
cohorts, but the construct of HIV stigma may not be defined
the same across cultures; utilizing a pre-existing scale in a
new, different culture may neglect the measurement of
culturally appropriate conceptions of the construct. Interest-
ingly, the studies that utilized both qualitative and quan-
titative measures revealed ways in which the quantitative
measures could fail to detect instances of stigma or beliefs
about stigma that the participants found to be highly
relevant on qualitative inquiry [28].
Conclusions
This review provides evidence of the various HIV stigma
measures being used to measure HIV stigma in paediatric
populations. The available quantitative HIV stigma measures
vary significantly, and few have been adapted for paediatric
and adolescent populations or for the resource-limited
settings in which most HIV-infected children live. Reliable,
valid measures to quantify HIV stigma for populations living
with HIV are critical to programmes’ ability to monitor and
reduce the impact of stigma.
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